John B. Porter

University College Hospital — United Kingdom

Medicine · Health Sciences

76h-index20.7kcitations707works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(434), Iron Metabolism and Disorders(263), Blood groups and transfusion(74), Erythrocyte Function and Pathophysiology(57), Pharmacological Effects and Toxicity Studies(55)

Publications701 total

Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study
Orphanet Journal of Rare Diseases·2025Open Access
Impact of long-term luspatercept treatment on iron parameters in patients with transfusion-dependent and non-transfusion-dependent β-thalassemia: Results from the phase 3b long-term follow-up study
Blood·2025
Achieving clinically meaningful changes in haemoglobin levels in patients with non‐transfusion‐dependent β‐thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 <scp>BEYOND</scp> trial
British Journal of Haematology·2025Open Access
Psychogenic respiratory distress - anxiety induced airway collapse.
PubMed·2025
Delayed Inflammatory Hypermetabolism in Meningioma After Immunotherapy
Clinical nuclear medicine open.·2025Open Access
Efficacy and safety of luspatercept in non–transfusion-dependent β-thalassemia: long-term results from the BEYOND study
Blood Advances·2025· 2 citedOpen Access
Switching Patients With Congenital Adrenal Hyperplasia to Modified‐Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control
Clinical Endocrinology·2025Open Access
Transfusional Iron Overload
2025
TIF Guidelines for the Management of Transfusion‐Dependent β‐Thalassemia
HemaSphere·2025· 7 citedOpen Access
Observational Data on Parvovirus B19 Cases in Patients with Red Cell Disorders in the United Kingdom from 2023-2024
Blood·2024· 1 cited
ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia
Blood·2024· 4 citedOpen Access
Improvement of Iron Overload Parameters in Patients with Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Data from the Phase 3b Long-Term Rollover Study Following the BELIEVE Trial
Blood·2024Open Access
9341 CHAMPAIN Study: Initial Results From A Phase II Study Of Efficacy, Safety And Tolerability Of Modified-release Hydrocortisones: Chronocort® (Efmody®) Versus Plenadren®, In Primary Adrenal Insufficiency
Journal of the Endocrine Society·2024· 1 citedOpen Access
Bone mineral density in adult thalassaemias: a retrospective longitudinal study
Nuclear Medicine Communications·2024
Incidence of adrenal crisis in Congenital Adrenal Hyperplasia (CAH) patients during a prospective monitored long-term study of modified-release hydrocortisone (MRHC) capsules, (Efmody)
Endocrine Abstracts·2024
Biochemical control with dose reduction in chronic glucocorticoid therapy over 4 years: A phase III extension study of Chronocort (Efmody) in the treatment of Congenital Adrenal Hyperplasia (CAH)
Endocrine Abstracts·2024
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency
Blood Advances·2024· 9 citedOpen Access
Sustained Efficacy and Safety in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)
Transplantation and Cellular Therapy·2024· 1 cited
Sustained Efficacy, Safety, and Improved Quality of Life in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)
Blood·2023· 6 cited
Improvement in Iron Burden in Patients with Transfusion-Dependent β-Thalassemia (TDT) Treated with Betibeglogene Autotemcel (Beti-cel) Gene Therapy: Up to 9 Years of Follow-up
Blood·2023· 1 cited
page 1 of 36Next →

Frequent Co-authors

Maria Domenica Cappellini(12), Robert C. Hider(11), Alì Taher(10), Dudley J. Pennell(9), Vip Viprakasit(7), Antonio Piga(7), John M. Walker(6), Bernard A. Davis(6), Antonis Kattamis(6), Dany Habr(6), Renzo Galanello(5), Alan R. Cohen(5), Yeşim Aydınok(5), Elliott Vichinsky(5), Lisa Anderson(4), Gian Luca Forni(4), Amal El‐Beshlawy(4), Mohsen Saleh Elalfy(4), Maciej Garbowski(4), Sy Ha(3)